T2 Biosystems to Attend Upcoming Investor Conferences
28 juil. 2023 08h30 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 28, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems to Report Second Quarter 2023 Financial Results on August 7, 2023
24 juil. 2023 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that...
T2 Biosystems Reports Granting of Inducement Award
21 juil. 2023 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 21, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to...
T2 Biosystems Receives FDA Breakthrough Device Designation for Candida Auris Diagnostic Test
20 juil. 2023 08h30 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems Announces Preliminary Second Quarter 2023 Financial Results
12 juil. 2023 08h30 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces Conversion of Approximately Twenty Percent of CRG Term Loan into Equity
06 juil. 2023 08h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 06, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces Clinical Collaboration with Vanderbilt University Medical Center to Implement and Evaluate the T2Bacteria Panel for Clinical Use
09 juin 2023 09h15 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., June 09, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced a...
T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for Candida Auris Diagnostic Test
05 juin 2023 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces Second Largest Sepsis-Driven Instrument Sale in Company History
30 mai 2023 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the...
T2 Biosystems Announces First Quarter 2023 Financial Results
23 mai 2023 08h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...